http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 22 Jul 2026 11:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ks.lenexa" idsrc="xmltag.org" >LENEXA, Kan.</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- Eurofins Viracor announces the commercial availability of the BKV inSIGHT™ <span>T-Cell Immunity Panel</span> (TCIP) (Test Code 33591), a novel immune monitoring assay designed to measure BK virus (BKV) -specific T-cell immunity in patients experiencing significant levels of BK viremia with recent onset. The assay provides clinicians with immune response information that may help identify patients with the capacity for immunological control of BK viral replication.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html Wed, 22 Jul 2026 11:00:00 -0400 A.06822034 EUFI O.20026344 http://www.streetinsider.com/Press+Releases/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ks.lenexa" idsrc="xmltag.org" >LENEXA, Kan.</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- Eurofins Viracor announces the commercial availability of the BKV inSIGHT™ <span>T-Cell Immunity Panel</span> (TCIP) (Test Code 33591), a novel immune monitoring assay designed to measure BK virus (BKV) -specific T-cell immunity in patients experiencing significant levels of BK viremia with recent onset. The assay provides clinicians with immune response information that may help identify patients with the capacity for immunological control of BK viral replication.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html Wed, 22 Jul 2026 11:00:00 -0400 A.06822034 EUFI O.20026344 http://www.streetinsider.com/Press+Releases/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ks.lenexa" idsrc="xmltag.org" >LENEXA, Kan.</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- Eurofins Viracor announces the commercial availability of the BKV inSIGHT™ <span>T-Cell Immunity Panel</span> (TCIP) (Test Code 33591), a novel immune monitoring assay designed to measure BK virus (BKV) -specific T-cell immunity in patients experiencing significant levels of BK viremia with recent onset. The assay provides clinicians with immune response information that may help identify patients with the capacity for immunological control of BK viral replication.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html Wed, 22 Jul 2026 11:00:00 -0400 A.06822034 EUFI O.20026344 http://www.streetinsider.com/PRNewswire/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ks.lenexa" idsrc="xmltag.org" >LENEXA, Kan.</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- Eurofins Viracor announces the commercial availability of the BKV inSIGHT™ <span>T-Cell Immunity Panel</span> (TCIP) (Test Code 33591), a novel immune monitoring assay designed to measure BK virus (BKV) -specific T-cell immunity in patients experiencing significant levels of BK viremia with recent onset. The assay provides clinicians with immune response information that may help identify patients with the capacity for immunological control of BK viral replication.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html Wed, 22 Jul 2026 11:00:00 -0400 A.06822034 EUFI O.20026344 http://www.streetinsider.com/PRNewswire/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ks.lenexa" idsrc="xmltag.org" >LENEXA, Kan.</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- Eurofins Viracor announces the commercial availability of the BKV inSIGHT™ <span>T-Cell Immunity Panel</span> (TCIP) (Test Code 33591), a novel immune monitoring assay designed to measure BK virus (BKV) -specific T-cell immunity in patients experiencing significant levels of BK viremia with recent onset. The assay provides clinicians with immune response information that may help identify patients with the capacity for immunological control of BK viral replication.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html Wed, 22 Jul 2026 11:00:00 -0400 A.06822034 EUFI O.20026344 http://www.streetinsider.com/PRNewswire/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ks.lenexa" idsrc="xmltag.org" >LENEXA, Kan.</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- Eurofins Viracor announces the commercial availability of the BKV inSIGHT™ <span>T-Cell Immunity Panel</span> (TCIP) (Test Code 33591), a novel immune monitoring assay designed to measure BK virus (BKV) -specific T-cell immunity in patients experiencing significant levels of BK viremia with recent onset. The assay provides clinicians with immune response information that may help identify patients with the capacity for immunological control of BK viral replication.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Eurofins+Viracor+Launches+BKV+inSIGHT%E2%84%A2+T-Cell+Immunity+Panel+to+Support+BK+Virus+Immune+Monitoring+in+Kidney+Transplant+Patients/26800110.html Wed, 22 Jul 2026 11:00:00 -0400 A.06822034 EUFI O.20026344 http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html <p>Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Siemens </span></span> Healthineers AG </span></span> (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> Align Technology </span></span> (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&amp;Nephew (LON:SN) to Hold.</p> <p>The revision comes as investors debate whether the recent correction in the sector presents a buy opportunity, or marks the start of a possible recession.</p> <p>“To make the matters worse, there are few frameworks to assess the degree of multiples compression that long-duration growth names might face if http://www.streetinsider.com/Investing/HSBC+shuffles+MedTech+stocks%2C+cutting+4%2C+upgrading+2/24687081.html Fri, 25 Apr 2025 09:09:36 -0400 ALGN BIOX EUFI IHI IQV LONN SHLG SN SOON STDM TMO XHE